Filed: 11/14/2023ACC: 0001645721-23-000012
📋 What this filing means
AQUILO CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $110.35M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$110.35M
Total AUM (reported)
10.59M
Total Shares
Allocation by class
COM$90.10M81.6%
ADS$12.89M11.7%
COM STK$3.70M3.4%
SPONSORED ADS$1.84M1.7%
SPONSORED ADR$1.83M1.7%
Portfolio Concentration
Top 3$57.40M52.0%
4–10$50.88M46.1%
11–25$2.08M1.9%
Top 3 weight
52.0%
Top 10 weight
98.1%
Voting Authority Distribution
Total shares with voting rights: 10.59M
Sole
Full voting authority
10.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
ARROWHEAD PHARMACEUTICALS IN
SOLEShares908.47K
TypeSH
Market value$24.41M
22.12%
Sole
908.47K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares379.09K
TypeSH
Market value$19.04M
17.25%
Sole
379.09K
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares847.42K
TypeSH
Market value$13.95M
12.64%
Sole
847.42K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares1.31M
TypeSH
Market value$12.89M
11.68%
Sole
1.31M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares782.22K
TypeSH
Market value$10.87M
9.85%
Sole
782.22K
Shared
0.00
None
0.00
MERUS N V
SOLEShares430.11K
TypeSH
Market value$10.14M
9.19%
Sole
430.11K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares489.15K
TypeSH
Market value$9.61M
8.71%
Sole
489.15K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares1.99M
TypeSH
Market value$3.70M
3.35%
Sole
1.99M
Shared
0.00
None
0.00
GENMAB A/S
SOLEShares52.15K
TypeSH
Market value$1.84M
1.67%
Sole
52.15K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares3.71K
TypeSH
Market value$1.83M
1.66%
Sole
3.71K
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares88.88K
TypeSH
Market value$1.10M
0.99%
Sole
88.88K
Shared
0.00
None
0.00
PIERIS PHARMACEUTICALS INC
SOLEShares3.30M
TypeSH
Market value$984.4K
0.89%
Sole
3.30M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARROWHEAD PHARMACEUTICALS INSOLE | COM | 908.47K | SH | $24.41M 22.12% | 908.47K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 379.09K | SH | $19.04M 17.25% | 379.09K | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 847.42K | SH | $13.95M 12.64% | 847.42K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 1.31M | SH | $12.89M 11.68% | 1.31M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 782.22K | SH | $10.87M 9.85% | 782.22K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 430.11K | SH | $10.14M 9.19% | 430.11K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 489.15K | SH | $9.61M 8.71% | 489.15K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 1.99M | SH | $3.70M 3.35% | 1.99M | 0.00 | 0.00 |
GENMAB A/SSOLE | SPONSORED ADS | 52.15K | SH | $1.84M 1.67% | 52.15K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 3.71K | SH | $1.83M 1.66% | 3.71K | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 88.88K | SH | $1.10M 0.99% | 88.88K | 0.00 | 0.00 |
PIERIS PHARMACEUTICALS INCSOLE | COM | 3.30M | SH | $984.4K 0.89% | 3.30M | 0.00 | 0.00 |